FDA
approval
· 2019-06-28
FDA Approved: MEMANTINE — Supplemental Application (Chartwell RX, LLC)
Summary
The FDA approved Chartwell RX LLC's supplemental application for memantine. This action approves a supplemental filing for a generic memantine product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MEMANTINE (MEMANTINE)